This inventor holds 43 USPTO granted patents and 47 published patent applications and 13 EPO patents, primarily in CRISPR Technology. Top assignees: Massachusetts Institute of Technology, The Broad Institute, Inc., Harvard College. Active years: 2017-2026.
Company Filing History:
43 out of 8,568Â 
36 out of 480Â 
34 out of 3,069Â 
Years Active: 2017-2026
Areas of Expertise:
Title: Jonathan S Gootenberg: Innovator in Nucleic Acid Editing and Rapid Diagnostics
Introduction:
Jonathan S Gootenberg is a renowned inventor and researcher based in Cambridge, MA, who has made significant contributions to the fields of nucleic acid editing and rapid diagnostics. With an impressive portfolio of 26 patents and his affiliation with respected institutions like the Massachusetts Institute of Technology (MIT) and The Broad Institute, Inc., Gootenberg has established himself as a leading figure in the world of innovation and scientific research.
Latest Patents:
One of Gootenberg's latest patents is titled "Systems, Methods, and Compositions for Targeted Nucleic Acid Editing." This groundbreaking invention focuses on developing engineered DNA-targeting systems, utilizing DNA-targeting Cpf1 proteins, guide molecules, and adenosine deaminase proteins. These systems enable precise targeting and editing of nucleic acids, holding immense potential for therapeutic applications and genetic research.
Another notable patent by Gootenberg involves "Rapid Diagnostics," which highlights the use of isothermal amplification reagents for the swift detection of microbial species, including the identification of the coronavirus. This innovation offers advanced diagnostic methodologies with the potential for rapid and accurate disease surveillance.
Career Highlights:
Throughout his career, Gootenberg has been associated with prestigious educational and research institutions, making significant contributions in the field of molecular biology and genetic engineering. While working at MIT and The Broad Institute, Gootenberg has showcased extensive expertise in the development of precise gene-editing tools and diagnostic technologies. His pioneering work has opened new pathways in the advancement of medicine and molecular biology.
Collaborations:
Gootenberg has collaborated with prominent figures in the scientific community, further amplifying the impact of his innovative inventions. Notably, he has worked alongside Feng Zhang, another standout researcher, and Omar O Abudayyeh. These collaborations have fostered groundbreaking advancements in gene-editing technologies, paving the way for novel therapeutic approaches and diagnostic tools.
Conclusion:
Jonathan S Gootenberg's contributions to the fields of nucleic acid editing and rapid diagnostics stand as remarkable achievements in the realm of innovation. His patents, focusing on targeted nucleic acid editing and the development of rapid diagnostic systems, have the potential to revolutionize genetic research, disease treatment, and diagnostics. As an inventor and researcher, Gootenberg continues to bring forth cutting-edge technologies that inspire and reshape the future of molecular biology and medical sciences.